Wutah dodolan YoY sajrone rolas wulan kepungkur: Agios Corp (AGIO)

Logo grafis Agios Corp (AGIO)

Agios Pharmaceuticals (AGIO) revenue dynamics rely on the commercialization of a single drug and external R&D funding. The current year-over-year sales trend over 12 months visualizes these factors, where the 215.40 metric determines the parameter status. Business stability is supported by oncology asset sales for cash flow and strict temperature control during the delivery of specialized medications.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Agios Pharmaceuticals Inc (AGIO) kanggo 11.02.2024 - 18.11.2026

agios.com (AGIO) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:AGIO, Agios Pharmaceuticals Inc
Produk seri Agios Pharmaceuticals

An investment audit of Agios Pharmaceuticals (AGIO) requires a prompt revenue analysis to evaluate drug commercialization rates. The LTM sales growth YoY is calculated as the ratio of total revenue over the last 12 months to the same period last year. For a company focused on strategic alliances and organic growth following the sale of its oncology portfolio, this metric confirms the effectiveness of new collaborations. This chart allows for the differentiation of a genuine technological breakthrough from risky dumping.

Karo sapa Agios Pharmaceuticals saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)